Effects of Antarctic krill docosahexaenoic acid on MCF-7 cell migration and invasion induced by the interaction of CD95 with caveolin-1

被引:14
作者
Zheng, Weilong [1 ]
Li, Jingda [1 ]
Wang, Xudong [1 ]
Yuan, Yanping [1 ]
Zhang, Jianing [2 ]
Xiu, Zhilong [1 ]
机构
[1] Dalian Univ Technol, Sch Life Sci & Biotechnol, 2 Linggong Rd, Dalian 116024, Peoples R China
[2] Dalian Univ Technol, Sch Life Sci & Med, 2 Dagong Rd, Panjin 124221, Peoples R China
关键词
Antarctic krill; DHA; CD95; Caveolin-1; Migration; Invasion; BREAST-CANCER; GROWTH; APOPTOSIS; ENHANCEMENT; SUPPRESSES; EFFICACY; RECEPTOR; THERAPY; DEATH; RAFTS;
D O I
10.1016/j.lfs.2017.11.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor metastasis leads to a poor prognosis in breast cancer, yet the mechanisms remain unclear. Docosahexaenoic acid (DHA) extracted from Antarctic krill is an optical isomer of common DHA and has a much stronger anti-neoplastic effect. In this work, the migration and invasion abilities of MCF-7 cells treated with low concentrations of Antarctic krill DHA were evaluated. Low concentrations of Antarctic krill DHA significantly reduced the numbers of migrating and invasive MCF-7 cells, whereas the cell numbers decreased slowly in the CD95-silenced MCF-7 cells, which implies that CD95 might be involved in cell migration and invasion. Additionally, co-immunoprecipitation and Western blotting demonstrated that Antarctic krill DHA induced the accumulation of CD95 and caveolin-1 interaction, resulting in the down-regulation of MMP2 expression through the FAK/SRC/PI3K/AKT signaling pathway. In conclusion, Antarctic krill DHA enhanced the interaction between CD95 and caveolin-1, which may led to an inhibitory effect on cell migration and invasion via the FAK/SRC/PI3K/AKT signaling pathway. Our study indicates that Antarctic krill DHA has great potential for tumor therapy and has revealed a new metastatic mechanism mediated by the interaction of CD95 with caveolin-1.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 43 条
[1]  
[Anonymous], BIOCH BIOPHYS ACTA
[2]  
[Anonymous], NAUSEA VOMITING CANC
[3]  
[Anonymous], 1993, INT J CANCER, DOI DOI 10.1002/ijc.2910540413
[4]  
[Anonymous], MOL CELL PHARM
[5]  
Anwar Sumadi Lukman, 2015, Asian Pac J Cancer Prev, V16, P6803
[6]  
BANG HO, 1976, ACTA MED SCAND, V200, P69
[7]   CANCER MORTALITY AMONG ALASKAN NATIVES, 1960-69 [J].
BLOT, WJ ;
LANIER, A ;
FRAUMENI, JF ;
BENDER, TR .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (03) :547-554
[8]  
Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3
[9]  
BROITMAN SA, 1992, ADV EXP MED BIOL, V322, P103
[10]   MYC in breast tumor progression [J].
Chen, Yinghua ;
Olopade, Olufunmilayo I. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) :1689-1698